Atlas Trials

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Clinical trial NCT00488761 · COMPLETED

Trial details

NCT number
NCT00488761
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Skin Diseases, Infectious
Start date
2006-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.